Panel Discussion | Is There a Role/Need for Bioresorbable and/or Bioadaptor Platforms?

Monday, March 10, 2025

11:59 AM - 12:25 PM ET

Panel Moderator(s)

Michael H. Joner, MD

Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany

No relationships to disclose
Yoshinobu Onuma, MD, PhD

Professor of Interventional Cardiology
University of Galway
Galway, Galway, Ireland

No relationships to disclose

Panel Discussant(s)

Andreas Baumbach, MD, FRCP, FESC

Chair
Queen Mary University of London
London, England, United Kingdom

Disclosure(s): Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Meril Lifesciences: Consultant (Ongoing); Pi-Cardia: Consulting Fees (e.g., advisory boards) (Ongoing)
Robert A. Byrne, MD, BCh, PhD

Director of Cardiology
Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
Dublin, Ireland

No relationships to disclose
Manish Doshi, PhD

Founder and Managing Director
Concept Medical, Florida, United States

No relationships to disclose
David Erlinge, MD, PhD

Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden

No relationships to disclose
Nicolas Foin, MSc, PhD

Founder/ Adj Associate Professor
Dhenin/ Duke-NUS Medical School
Brussels, Brussels Hoofdstedelijk Gewest, Belgium

No relationships to disclose
Sahil A. Parikh, MD, FSCAI

Associate Professor of Medicine
Columbia University Irving Medical Center
New York, New York, United States

No relationships to disclose
Richard J. Rapoza, PhD

Divisional Vice President, Global Research and Development
Abbott Vascular
Santa Clara, California, United States

Disclosure(s): Abbott Labs: Employee (Ongoing), Salary (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
Pieter C. Smits, PhD, FESC

Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands

No relationships to disclose
Ruben Yannick Gerold Tijssen, MD, PhD

MD, PhD
St. Antonius Ziekenhuis Nieuwegein, the Netherlands
Naarden, Noord-Holland, Netherlands

No relationships to disclose

Disclosure(s):

Michael H. Joner, MD: No financial relationships to disclose

Yoshinobu Onuma, MD, PhD: No financial relationships to disclose

Andreas Baumbach, MD, FRCP, FESC: Biotronik: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Meril Lifesciences: Consultant (Ongoing); Pi-Cardia: Consulting Fees (e.g., advisory boards) (Ongoing)

Robert A. Byrne, MD, BCh, PhD: No financial relationships to disclose

Manish Doshi, PhD: Concept Medical: Employee (Ongoing), Stock-privately held company (Ongoing)

David Erlinge, MD, PhD: No financial relationships to disclose

Nicolas Foin, MSc, PhD: CoreAalst: Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Medinbox: Consultant (Ongoing), Exec. Board, Mandate (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Sahil A. Parikh, MD, FSCAI: Abbott Vascular: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Acotec: Grant/Research Support (Ongoing); Advanced NanoTherapies: Stock-privately held company (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Concept Medical: Grant/Research Support (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Efemoral Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Encompass vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); R3 Vascular: Grant/Research Support (Ongoing); Reflow Medical: Grant/Research Support (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Veryan Medical: Grant/Research Support (Ongoing)

Richard J. Rapoza, PhD: Abbott Labs: Employee (Ongoing), Salary (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Pieter C. Smits, PhD, FESC: CERC ( centre european of cardiovascular research): Consultant (Ongoing), Stock-privately held company (Ongoing)

Ruben Yannick Gerold Tijssen, MD, PhD: No financial relationships to disclose